symplr, a leading global healthcare governance, risk management, and compliance software-as-a-service platform, backed by Clearlake Capital Group, L.P. and SkyKnight Capital, today announced that it has signed a definitive agreement to acquire TractManager from Arsenal Capital Partners.
Revolution, a leading manufacturer of sustainable plastic solutions, today announced that it has acquired Polar Plastics Corporation from Spell Capital Partners in order to expand its production footprint and further penetrate the packaging, agriculture and retail sectors with environmentally friendly products.
Polytek Development Corp., a manufacturer of specialty polymers for mold making, casting, and coating applications, announced today the acquisition of Incredible Solutions. Polytek is a portfolio company of Arsenal Capital Partners.
Arsenal Capital Partners, a private equity firm that specializes in investments in healthcare and industrial companies, today announced its partnership with Dr. Richard Eglen as a Senior Advisor to its healthcare team. Dr. Eglen will work with Arsenal’s healthcare team to further develop life science tools and reagents investment themes. He will also serve as both a member of the Scientific Advisory Board and an advisor to the Board of Directors of BioIVT, an Arsenal portfolio company that is a global leader in providing in vitro research models and services for drug and diagnostic development.
Arsenal Capital Partners, a specialized private equity firm investing in healthcare and industrials companies, has completed the acquisition of Cello Health plc, the global healthcare-focused advisory firm, for a total enterprise value of £181.8 million.
